Bangladesh based Healthcare Pharmaceuticals Ltd. (HPL) and Eli Lilly & Company announced the launch of CYRAMZA™ (ramucirumab injection, 10 mg/mL solution) in Bangladesh. Cyramza™, is an anti-cancer medicine that is approved as a single agent and/or in combination with other agents for cancers arising from stomach, lungs, liver or large
